Owing to the fact that marker testing on curettage samples has proven equally reliable as on hysterectomy specimens 25, 26, it might be proposed to use L1CAM in the preoperative risk stratification to predict lymph node metastasis in endometrial cancer. The gene discussed is L1CAM; the disease is metastatic malignant neoplasm in the lymph nodes.